Use of Autologous hematopoietic stem cell transplantation for a patient with primary nasal NK/T-cell lymphoma combined with hemophagocytic syndrome

Mingquan Xing; Chunbo  Feng; Weixia Wu; Yanrong Zhang; Siqi Zhang; Xiaoxing Sun; Hongfeng Ge

doi:10.71321/sx17sm66

Authors

Mingquan Xing Department of Hematology, Bozhou People's Hospital,BoZhou
Chunbo Feng Otolaryngology department,Bozhou People's Hospital,BoZhou, Anhui, People’s Republic of China
Weixia Wu Image Center, Bozhou People's Hospital,BoZhou, Anhui, People’s Republic of China
Yanrong Zhang Department of Hematology, Bozhou People's Hospital,BoZhou, Anhui, People’s Republic of China
Siqi Zhang Department of Hematology, Bozhou People's Hospital,BoZhou, Anhui, People’s Republic of China
Xiaoxing Sun Department of Hematology, Bozhou People's Hospital,BoZhou, Anhui, People’s Republic of China
Hongfeng Ge Department of Hematology, Bozhou People's Hospital,BoZhou, Anhui, People’s Republic of China

DOI:

https://doi.org/10.71321/sx17sm66

Keywords:

Extranodal NK/T-cell lymphoma, hemophagocytic syndrome, autologous hematopoietic stem cell transplantation

Abstract

Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) is a type of primary nasal peripheral T-cell lymphoma, which is a rare type of non-Hodgkin's lymphoma, especially with hemophagocytic syndrome (HPS), and can easily lead to clinical misdiagnosis. The disease is dangerous, it progresses rapidly, and the treatment is ineffective. This article reports a case of ENKTCL-NT with HPS, which involves the primary nasal cavity invading the oral cavity. Patients attain improved remission outcomes with autologous hematopoietic stem cell transplantation (ASCT) in combination with chemotherapy. This paper reviews current domestic and international research and summarizes diagnostic and therapeutic approaches to enhance clinicians' comprehension of the disease.

References

[1] Chan CY, Lin TL, Kuo MC, Hung YS, Chang H, Ou CW, et al. Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas. Ann Med. 2025 Dec;57(1):2478315. https://doi.org/10.1080/07853890.2025.2478315

[2] Lei Y, Qiu Y, Huang W, Wang T, Kang L. Incidental finding of subclinical cardiac involvement by [18F]FDG PET/CT in Nasal-Type extranodal NK/T-Cell lymphoma. Eur J Nucl Med Mol Imaging. 2025 Apr 7. https://doi.org/10.1007/s00259-025-07250-x

[3] Li W, Yang C, Lv Z, Li J, Li Z, Yuan X,et al. Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma. J Cancer. 2021;12(9):2715-2722. Published 2021 Mar 5. https://doi.org/10.7150/jca.56397

[4] Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, Santos-Silva AR, Prado-Ribeiro AC, Brandão TB,et al. Extranodal NK/T cell lymphoma, nasal type: An updated overview. Crit Rev Oncol Hematol. 2021;159:103237. https://doi.org/10.1016/j.critrevonc.2021.103237

[5] Sun Y, Liu H, Xie P, Zhu P, Meng X. The CT findings of extranodal natural killer/T-cell lymphoma, nasal type involving the gastrointestinal tract. Eur Radiol. Published online January 29, 2025. https://doi.org/10.1007/s00330-025-11369-8

[6] Fan F, Liu J, Liu S, Xu Y, Wang X, Yan Y, et al. Advances in diagnosis and treatment of lymphoma-associated hemophagocytic syndrome. Am J Transl Res. 2025;17(3):1604-1612. Published 2025 Mar 15. https://doi.org/10.62347/TVTB3045

[7] Li N, Jiang M, Wu WC, Zhou HJ, Zou LQ. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center. Hematology. 2022;27(1):909-916. https://doi.org/10.1080/16078454.2022.2113600

[8] Fan F, Liu J, Liu S, Xu Y, Wang X, Yan Y, et al. Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature. Ann Hematol. 2025;104(5):3001-3006. https://doi.org/10.1007/s00277-025-06260-x

[9] Masui H, Shindo M, Inoue Y, Sugiyama M, Ueda A, Shindo T, et al. Successful treatment of severe splenic lymphoma-associated hemophagocytic syndrome by splenectomy and subsequent chemotherapy: A case report. Oncol Lett. 2024;27(5):222. Published 2024 Mar 22. https://doi.org/10.3892/ol.2024.14355

[10] Fulati W, Ma J, Wu M, Qian W, Chen P, Hu Y, et al. Consolidation therapy with autologous stem cell transplantation after remission of induction chemotherapy prolongs the survival of patients with peripheral T-cell lymphoma. Front Immunol. 2024 May 10;15:1382189. https://doi.org/10.3389/fimmu.2024.1382189